Forum on Cancer and Immuno-Oncology Part 1

Salva sul calendario
Da 13.06.2019 14:00 fino a 13.06.2019 18:00
Inserito da Amministrazione
Visite: 700

Sala convegni Fondazione EBRIS
Via De Renzi, 50 Salerno

The Conference will be accredited for N. 50 italian following professionals:

  • Medical Doctor: Allergology and Clinical Immunology, Clinical Pathology, Dermatology, Ematology, General Surgery, Medical Genetics, Nephrology, Nuclear Medicine, Oncology, Pathological Anatomy, Plastic Surgery, Radiodiagnostic and Radiotherapeutic, Respiratory Medicine, Thoracic Surgery, Urology, Gynecology and Obstetrics.
  • Biologists
  • Hospital pharmacist

ECM N° 261062 - CREDITS: 4 - Acquisition of Credits under current Age.na.s legislation

Registrations exclusively through the website www.strategieonweb.it

RATIONALE

Today the immuno-oncology (I-O) represents a revolution in the field of oncology.
The checkpoints inhibitors (anti-CTLA4, anti-PD-1, etc.), are able to kill cancer cells indirectly, through the interaction with the immune system cells. The characteristics of adaptability and memory of the immune-system make it able to reach longterm survival (more than 10 years). For this reason, I-O became the fourth pillars in the treatment of cancer together surgery, radiotherapy, and chemotherapy.

After the excellent results reached in different type of cancers, I-O is exploring a wide range of new molecules and possible combinations or sequencing, in order to increase the number of patients with a long-term benefit.

The intent of this course, with contributions from Società Campana di Immunoncologia (SCITO) is to offer a general educational overview about the topics described. In addition, thanks to the contribution of Karolinska Institute of Stockholm, this course goes beyond national borders taking on an international aspect.

PROGRAM

14.00 Welcome & Registration
14.30 Introduction and Objectives
Sabino De Placido - Clementina Savastano

SESSION: UPDATE AND NEW TRENDS IN CANCER IMMUNO-ONCOLOGY

14.45 Chair Vincenzo Montesarchio
Melanoma: Emerging strategies and future perspectives.
Speaker Paolo Antonio Ascierto
Debate

15.15 Chair Giacomo Cartenì
Immunotherapy evolution for lung carcinoma
Speaker Cesare Gridelli
Debate

15.45 Chair Giuseppe Palmieri
Immunotherapy in colorectal cancer: what's new
Speaker Antonio Avallone

Debate
16.15 Chair Corrado Caracò - Paolo Antonio Ascierto SCITO meets Karolinska Cancer Institute

The relevance of biomarkers as prognostic and predictive tools in immunotherapy - Pascale and KI collaboration Speaker Giuseppe Masucci

Innovative Diagnostics for Solid Tumors The Karolinska Institutet Model. Speaker Rolf Lewensohn
Debate

SESSION: SCITO YOUTH
16.45 Chair Ester Simeone Projects and activities Speaker Margaret Ottaviano Debate

17.15 ROUND TABLE: Inter-regional collaborations in cancer immunotherapy: ideas, proposals, opportunities
Chair Paolo Antonio Ascierto
Discussants: Michele Aieta, Andrea Botticelli, Michele Guida Evaristo Maiello, Gennaro Palmiotti

18.00 Conclusions: Clementina Savastano

 






Segui i canali tematici su Telegram:

Telegram.pngAGRIFOOD
Telegram.png AMBIENTE ED ENERGIA
Telegram.pngSANITA'
Telegram.pngPOLITICA
Telegram.pngECONOMIA


 

 

 

Categorie Principali

politica

Iscriviti alla newsletter

Iscriviti

Scegli il campo d'interesse
­